SEC Form 4 · accession 0001202094-26-000004
Inhibrx Biosciences, Inc. · INBX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimberly Manhard
Director
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 7:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002007919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2026 | S | 500 | $115.14 | D | 9,500 | I | Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 |
| Common StockF1 | Sep 9, 2026 | S | 500 | $115.795 | D | 9,000 | I | Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are directly owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012. Kimberly Manhard is a trustee of the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012.